latest news releases from the newsroom
Michelex, Corp. Hires NY Investment Banking Firm JH Darbie & Co. Inc. to Complete the Purchase of AGPro Soybean Processing and Oil Assets as Well as to Fuel Anticipated Ramp Up in Business
MASSENA, N.Y., Jan. 25, 2007 (PRIME NEWSWIRE) -- Michelex Corp. (Pink Sheets:MLXO) ("Michelex" or the "Company"), a plastic manufacturing company with its offices in Utah, and an audio record production group located in New York announced today that it has signed an Exclusive Investment Banking agreement with JH Darbie, located 99 Wall Street New York, to arrange financing for up to $5 million, in order to consummate the purchase of the AGPro soybean crushing and soybean oil refining assets located at Massena, New York in St. Lawrence County. JH Darbie has stated several factors that lend insight toward their confidence in carrying out this raise, geared to enable Michelex to enter the rapidly growing soybean oil refining and processing business.
Samaritan Pharmaceuticals, Inc.
Samaritan Pharma's SP-10 Hip On Hep C
LAS VEGAS, Jan. 25, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce today that an in-vitro study conducted on its oral entry inhibitor SP-10 by the National Institutes of Allergy and Infectious Diseases (NIAID), found SP-10 to have significant antiviral activity with Hepatitis C Virus (HCV) infection.
Tribeworks Acquires BLive Networks, Inc. and 700 New Customers
GZIRA, Republic of Malta, Jan. 25, 2007 (PRIME NEWSWIRE) -- Tribeworks, Inc. (OTCBB:TWKS) announced that it has entered into an agreement to acquire all of the assets and 700 customers of BLive Networks, Inc., further expanding Tribework's capability of delivering high quality outsourced support into the US$220 Billion annual IT Support market.
Advanced Medical Isotope Corporation
Advanced Medical Isotopes Corporation Licenses Patent for Producing Scarce Alpha-Emitting Medical Isotope, Actinium-225
KENNEWICK, Wash., Jan. 25, 2007 (PRIME NEWSWIRE) -- Advanced Medical Isotopes Corporation's (Pink Sheets:ADMD) Chief Executive Officer, William Stokes, is pleased to announce the licensing of United States Patent 6,680,993. Stokes said, "This patent is involved with the methods and processes directed to the preparation of Actinium-225 and daughters having high radiochemical and radionuclidic purity, which may be used for the preparation of radiopharmaceuticals for linkage to therapeutics such as those containing monoclonal antibodies, proteins, peptides, antisense, statin, natural products and hormones. Most importantly, the alpha-emitting radionuclide Actinium-225 and daughters can be used for both therapeutic and diagnostic purposes."